PFM
IONS icon

Privium Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

Privium Fund Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.4M Buy
319,924
+29,900
+10% +$2.25M 4.66% 5
2026
Q1 		$21.8M Buy
290,024
+49,200
+20% +$3.88M 4.53% 7
2025
Q4 		$19.1M Sell
240,824
-8,070
-3% -$608K 3.51% 7
2025
Q3 		$16.3M Sell
248,894
-18,700
-7% -$913K 2.93% 10
2025
Q2 		$10.7M Hold
267,594
– – 2.31% 9
2025
Q1 		$8.07M Buy
267,594
+800
+0.3% +$26.2K 2.1% 8
2024
Q4 		$9.33M Buy
266,794
+16,050
+6% +$600K 2.11% 12
2024
Q3 		$10M Buy
250,744
+3,477
+1% +$162K 2.5% 11
2024
Q2 		$11.2M Buy
247,267
+20,274
+9% +$832K 2.85% 9
2024
Q1 		$9.84M Buy
226,993
+9,500
+4% +$453K 2.63% 11
2023
Q4 		$11.5M Sell
217,493
-11,000
-5% -$527K 3.2% 7
2023
Q3 		$10.4M Buy
228,493
+2,000
+0.9% +$82.5K 3.08% 8
2023
Q2 		$9.31M Buy
226,493
+43,720
+24% +$1.68M 2.68% 13
2023
Q1 		$6.53M Buy
182,773
+33,966
+23% +$1.28M 2.19% 17
2022
Q4 		$5.56M Hold
148,807
– – 2.11% 16
2022
Q3 		$6.59M Sell
148,807
-31,300
-17% -$1.32M 2.39% 11
2022
Q2 		$6.67M Hold
180,107
– – 2.21% 14
2022
Q1 		$6.67M Sell
180,107
-450,092
-71% -$14.7M 1.47% 23
2021
Q4 		$19.2M Buy
+630,199
New +$19.8M 3.82% 7

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Privium Fund Management's IONS Position: Q2 2026 in Review

Privium Fund Management increased its Ionis Pharmaceuticals (IONS) stake by 10% in Q2 2026, buying an estimated $2.25M and bringing the position to 319,924 shares worth $25.4M. The position accounts for 4.66% of the portfolio, ranked #5.

Privium Fund Management first reported a position in IONS in Q4 2021 and has held it in 19 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Privium Fund Management held 319,924 shares of Ionis Pharmaceuticals worth $25.4M as of Q2 2026.
  • Privium Fund Management bought 29,900 Ionis Pharmaceuticals shares in Q2 2026, an estimated $2.25M.
  • Ionis Pharmaceuticals made up 4.66% of Privium Fund Management's portfolio in Q2 2026, its #5 holding.
  • Privium Fund Management first reported a position in Ionis Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Privium Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.